From: Subjective experiences of neurocognitive functioning in young people with major depression
Participant | Current vocation | Current mental health medication | Self-reported treatment length | Self-reported age of depression onset |
---|---|---|---|---|
P1 | Tertiary study | Fluoxetine (80 mg) | 1 year | 11–12 years |
P2 | School (Year 12) | Fluoxetine (20 mg) | 5 months | 12–13 years |
P3 | Tertiary study | Pristiq | 11 months | 16 years |
P4 | Tertiary study and work | Sertraline (100 mg) | 5 months | 12 years |
P5 | Not currently working or studying | Antidepressant - couldn’t recall name | 7 months | 15 years |
P6 | Work | Mood stabiliser – couldn’t recall name. | 4 months | 22 years |
P7 | Tertiary study, about to commence work | Fluoxetine (25 mg) | 3 months | 15 years |
P8 | Tertiary study | Sertraline (200 mg) | 4 months | 15 years |
P9 | Not currently working or studying | Fluoxetine (40 mg) | 2 months | 14 years |
P10 | Not currently working or studying | Fluoxetine | 12 months | 12 years |
P11 | Tertiary study | Escitalopram (20 mg), Mirtazapine (7.5 mg) | 6 months | 14 years |